Light-triggerable formulations for the intracellular controlled release of biomolecules

Drug Discov Today. 2018 May;23(5):1062-1070. doi: 10.1016/j.drudis.2018.01.019. Epub 2018 Jan 8.

Abstract

New therapies based on the use of biomolecules [e.g., proteins, peptides, and non-coding (nc)RNAs] have emerged during the past few years. Given their instability, adverse effects, and limited ability to cross cell membranes, delivery systems are required to fully reveal their biological potential. Sophisticated nanoformulations responsive to light offer an excellent opportunity for the controlled release of these biomolecules, enabling the control of timing, duration, location, and dosage. In this review, we discuss the design principles for the delivery of biomolecules, in particular proteins and RNA-based therapeutics, by light-triggerable formulations. We further discuss the opportunities offered by these formulations in terms of endosomal escape, as well as their limitations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / radiation effects
  • Drug Carriers* / administration & dosage
  • Drug Carriers* / radiation effects
  • Lasers
  • Light*
  • Nanostructures* / administration & dosage
  • Nanostructures* / radiation effects
  • Peptides / administration & dosage
  • Proteins / administration & dosage
  • RNA / administration & dosage

Substances

  • Delayed-Action Preparations
  • Drug Carriers
  • Peptides
  • Proteins
  • RNA